Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_assertion evidence source_evidence_literature NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_assertion SIO_000772 17456787 NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_assertion wasDerivedFrom befree-20140225 NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_assertion wasGeneratedBy ECO_0000203 NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.